Patents by Inventor Haresh G. Bhagat

Haresh G. Bhagat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOPICAL GATIFLOXACIN FORMULATIONS
    Publication number: 20080199537
    Abstract: Topical ophthalmic solution compositions of gatifloxacin are disclosed. The compositions do not contain disodium edetate or any other metal chelating agent.
    Type: Application
    Filed: February 15, 2008
    Publication date: August 21, 2008
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Haresh G. Bhagat, Ramon L. Espino
  • Olopatadine formulations for topical administration
    Patent number: 7402609
    Abstract: Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the eye and nose are disclosed. The aqueous formulations contain approximately 0.17-0.62% (w/v) of olopatadine and an amount of polyvinylpyrrolidone or polystyrene sulfonic acid sufficient to enhance the physical stability of the formulations.
    Type: Grant
    Filed: March 15, 2005
    Date of Patent: July 22, 2008
    Assignee: Alcon, Inc.
    Inventors: Ernesto J. Castillo, Wesley Wehsin Han, Huixiang Zhang, Haresh G. Bhagat, Onkar N. Singh, Joseph Paul Bullock, Suresh C. Dixit
  • Topical brimonidine tartrate formulations that lack chlorine dioxide
    Patent number: 7265117
    Abstract: Topical solution compositions of brimonidine tartrate are disclosed. The solution compositions lack an oxidative preservative.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: September 4, 2007
    Assignee: Alcon, Inc.
    Inventors: Ramon L. Espino, Haresh G. Bhagat
  • Olopatadine formulations for topical administration
    Patent number: 6995186
    Abstract: Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the eye and nose are disclosed. The aqueous formulations contain approximately 0.17-0.62% (w/v) of olopatadine and an amount of polyvinylpyrrolidone or polystyrene sulfonic acid sufficient to enhance the physical stability of the formulations.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: February 7, 2006
    Assignee: Alcon, Inc.
    Inventors: Ernesto J. Castillo, Wesley Wehsin Han, Huixiang Zhang, Haresh G. Bhagat, Onkar N. Singh, Joseph Paul Bullock, Suresh C. Dixit
  • Use of an anti-allergy agent and a steroid to treat nasal conditions
    Publication number: 20040097474
    Abstract: Compositions and methods for treating rhinitis with certain combinations of antiallergic agents and steroids are disclosed.
    Type: Application
    Filed: November 12, 2003
    Publication date: May 20, 2004
    Applicant: Alcon, Inc.
    Inventors: Gerald D. Cagle, G. Michael Wall, John M. Yanni, Rajni Jani, Haresh G. Bhagat
  • Olopatadine formulations for topical administration
    Publication number: 20030055102
    Abstract: Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the eye and nose are disclosed. The aqueous formulations contain approximately 0.17-0.62% (w/v) of olopatadine and an amount of polyvinylpyrrolidone or polystyrene sulfonic acid sufficient to enhance the physical stability of the formulations.
    Type: Application
    Filed: June 19, 2002
    Publication date: March 20, 2003
    Applicant: Alcon, Inc.
    Inventors: Ernesto J. Castillo, Wesley Wehsin Han, Huixiang Zhang, Haresh G. Bhagat, Onkar N. Singh, Joseph Paul Bullock, Suresh C. Dixit
  • Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
    Patent number: 6429227
    Abstract: HETE salts, the preparation of HETE salts, the preparation of stable and efficacious HETE compositions, HETE compositions and methods of use for treating dry eye are disclosed.
    Type: Grant
    Filed: October 23, 2000
    Date of Patent: August 6, 2002
    Assignee: Alcon Universal Ltd.
    Inventors: L. Wayne Schneider, Raymond E. Conrow, Daniel A. Gamache, Terri Pasquine, John M. Yanni, Haresh G. Bhagat
  • Topical composition comprising ciprofloxacin and hydrocortisone
    Publication number: 20020037884
    Abstract: This invention is directed toward a topical composition comprising ciprofloxacin and hydrocortisone, where the composition contains a specific grade of polyvinyl alcohol as a viscosity augmenter. The specified grade of polyvinyl alcohol is 85-90% hydrolyzed polyvinyl alcohol.
    Type: Application
    Filed: July 16, 2001
    Publication date: March 28, 2002
    Applicant: Alcon Universal Ltd.
    Inventors: Onkar N. Singh, Haresh G. Bhagat, Bhagwati P. Kabra
  • Topical suspension formulations containing ciprofloxacin and dexamethasone
    Patent number: 6359016
    Abstract: Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically stable and easily re-suspended. The formulations are intended for topical application to the eye, ear or nose.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: March 19, 2002
    Assignee: Alcon Universal Ltd.
    Inventors: Onkar N. Singh, Haresh G. Bhagat
  • Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
    Patent number: 6353022
    Abstract: Compositions containing one or more HETE derivative(s) and an effective concentration of ethanol and methods of use for treating dry eye are disclosed.
    Type: Grant
    Filed: October 23, 2000
    Date of Patent: March 5, 2002
    Assignee: Alcon Universal Ltd.
    Inventors: L. Wayne Schneider, Daniel A. Gamache, Lori K. Weimer, Timothy L. Kessler, Zhongyou Wei, Terri Pasquine, John M. Yanni, Haresh G. Bhagat
  • Topical solution formulations containing an antibiotic and a corticosteroid
    Publication number: 20010049366
    Abstract: Solution formulations containing a corticosteroid, an antibiotic and a vitamin E tocopheryl derivative as a solubilizing agent are disclosed. The formulations are intended for topical application to the eye, ear, nose or skin.
    Type: Application
    Filed: February 8, 2001
    Publication date: December 6, 2001
    Applicant: Alcon Universal Ltd.
    Inventors: Onkar N. Singh, Haresh G. Bhagat
  • Topical suspension formulations containing ciprofloxacin and dexamethasone
    Publication number: 20010034339
    Abstract: Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically stable and easily re-suspended. The formulations are intended for topical application to the eye, ear or nose.
    Type: Application
    Filed: May 25, 2001
    Publication date: October 25, 2001
    Inventors: Onkar N. Singh, Haresh G. Bhagat
  • Topical suspension formulations containing ciprofloxacin and dexamethasone
    Patent number: 6284804
    Abstract: Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically stable and easily re-suspended. The formulations are intended for topical application to the eye, ear or nose.
    Type: Grant
    Filed: August 10, 2000
    Date of Patent: September 4, 2001
    Assignee: Alcon Universal Ltd.
    Inventors: Onkar N. Singh, Haresh G. Bhagat
  • Combinations of polymers for use in physiological tear compositions
    Patent number: 5460834
    Abstract: The use of physiological tear compositions for the treatment of dry eye syndrome. The compositions have a high viscosity and contain bicarbonate, at least one cellulosic polymer and at least one carboxy vinyl polymer.
    Type: Grant
    Filed: January 10, 1995
    Date of Patent: October 24, 1995
    Assignee: Alcon Laboratories, Inc.
    Inventor: Haresh G. Bhagat
  • Physiological tear compositions and methods for their preparation
    Patent number: 5403598
    Abstract: Non-preserved physiological tear compositions comprise the ionic components of normal human tear film in substantially the same amounts and proportions. Novel methods of preparation of these compositions and novel packaging allow the maintenance of the bicarbonate concentration in these compositions.
    Type: Grant
    Filed: January 6, 1994
    Date of Patent: April 4, 1995
    Assignee: Alcon Laboratories, Inc.
    Inventors: Robert E. Beck, Haresh G. Bhagat, Philip D. Gressel, Fred M. Killinger
  • Anti-acne compositions
    Patent number: 4514385
    Abstract: Anti-acne preparations include finely divided, dispersed particles of benzoyl peroxide and finely divided, dispersed particles of salicylic acid in an aqueous gel formed from carboxy vinyl polymer resins. The gels are prepared without loss of salicylic acid by fully hydrating the resin in an aqueous medium and allowing the resin to gel in the absence of an alkaline neutralizing agent.
    Type: Grant
    Filed: October 5, 1981
    Date of Patent: April 30, 1985
    Assignee: Alcon Laboratories, Inc.
    Inventors: Nalinkant C. Damani, Haresh G. Bhagat, Ramon L. McElhaney